Position
Ethic Inc. in C4 Therapeutics, Inc.
Back to the book · All holders of CCCC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $7.29K$1.91 → $2.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10.3K | $19.6K | — | — | — | 0.0% |
| Q1 2026 | 10.1K | $26.6K | $2.63 | $7.29K | −$281 | 0.0% |